Archives

by in
Entry Author Date Location
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Madison Vaccine to be Tested in Combination Prostate Cancer Treatment 08/28/14 Wisconsin
Texas Roundup: New Funds for Bellicum, AirStrip, and Green & Grow 08/28/14 Texas
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
Madison Startup Rides Immunotherapy Wave With Prostate Drug 08/18/14 Wisconsin
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
West Coast Biotech Roundup: Volcano, Twist, Calibr, ARMO, and More 05/29/14 San Francisco
Hutch Starts Search for New Prez as Corey Steps Down 05/08/14 Seattle
Genentech Joins “What’s Hot in Cancer Immunotherapy” Apr. 22 03/07/14 Seattle
Merck Joins ‘What’s Hot in Cancer Immunotherapy’ Apr. 22 03/04/14 Seattle
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal 01/13/14 Seattle
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
Baseball and Biopharma: More Alike Than You Might Realize 07/03/13 Seattle
UK-based Cell Medica Lands in Texas To Seek Cancer Therapy 06/14/13 Texas
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Merck Joins Bristol, Genentech in Great Cancer Immunotherapy Race 06/02/13 New York
Check KUOW’s “Weekday” for Science News 05/17/13 Seattle
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Gradalis’s Fang Bares Its Teeth in Fighting Ovarian Cancer 05/15/13 Texas
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Page 1 of 2 next page »